Sort
48,018 grants matching “immunotherapy”
Boston Pediatric AIDS Clinical Trials Unit
$981,946Children'S Hospital Boston · U01 · FY2004 · AI
Stem Cell Biology, Cancer Stem Cell Biology, and Cancer Immunotherapy
$981,896Irving Lerner Weissman · Stanford University · R35 · FY2019 · CA
Modeling based design of chimeric antigen receptors for Natural Killer cell-based immunotherapy
$981,496Stacey Deleria Finley · University Of Southern California · U01 · FY2025 · CA
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
$981,463Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A Therapeutic Vaccine for Chronic Hepatitis B
$981,428David R. Milich · Vlp Biotech, Inc. · R44 · FY2014 · AI
Advancing a Glioma Immunotherapy
$981,388Dwaine Franklin Emerich · In Cytu, Inc. · R44 · FY2013 · NS
LEVERAGING DIGITAL PATHOLOGY AND DEEP LEARNING TO PREDICT IMMUNOTHERAPY RESPONSE.
$980,839The University Of Texas Southwestern Medical Center · · FY2021 · Defense Health Agency
A Rational Systematic Approach to Find Combinations of Pharmacologic and Immune Therapies that Target Identifiable Oncogenic States
$980,283Pablo Tamayo · University Of California, San Diego · U01 · FY2019 · CA
P1 - COMBINATION ACTIVATED T-CELL AND VACCINE THERAPY IN MYELOMA
$980,225Larry W Kwak · University Of Tx Md Anderson Can Ctr · P50 · FY2010 · CA
Integrating targeted and immunotherapy to treat genetically heterogeneous cancers
$980,118William A Weiss · University Of California, San Francisco · U01 · FY2019 · CA
Missouri Valley Cancer Consortium CCOP
$980,000Missouri Valley Cancer Consortium, Inc. · U10 · FY2002 · CA
Molecular, Cellular, and Tissue Characterization Unit
$979,965William E Gillanders · Washington University · U2C · FY2022 · CA
Lung cancer in East Africa and the relationship to HIV-1 infection: epidemiology, molecular characterization and imaging
$979,825Robert A Salata · Case Western Reserve University · U54 · FY2023 · CA
Development of a therapeutic nanobody targeting brain TNFa for the treatment of Alzheimer Disease
$979,592Marco Taglietti · Nanonewron Llc · R42 · FY2025 · AG
Core Center of Excellence in Hematology
$979,586Beverly J Torok-Storb · Fred Hutchinson Cancer Research Center · P30 · FY2010 · DK
Immunology of aging and immunotherapy of aging-associated diseases
$979,308Arya Biragyn · National Institute On Aging · ZIA · FY2023 · AG
Comprehensive Assessment of Cancer Immunotherapy Response
$979,163Timothy Perk · Aiq Solutions, Inc. · R44 · FY2023 · CA
Immunological Analysis of Brain Cancer
$979,154Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Regulation of innate lymphocyte function
$978,700Eric O Long · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.
$978,693Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · U01 · FY2023 · CA
Humanization, Production, and PK/PD Characterization of anti-TIP1 antibody against Non-Small Cell Lung Cancer
$978,235Sapna Deore · Medical Guidance Systems, Llc · R44 · FY2020 · CA
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$978,174James L Riley · University Of Pennsylvania · U19 · FY2021 · AI
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
$978,042James L Riley · University Of Pennsylvania · U19 · FY2023 · AI
Immunology of aging and immunotherapy of aging-associated diseases
$977,820Bira Arya · National Institute On Aging · ZIA · FY2015 · AG
Targeting S6K2 to Overcome Drug Resistance in NRAS-mutant Melanoma
$977,758Jessie Villanueva · Wistar Institute · R01 · FY2025 · CA